close

Enter

Log in using OpenID

26 Conflict of Interest Statement

embedDownload
26 Conflict of Interest Statement
Esempi: Advisory boards, consulting fees, research grants, speakers bureau, economical support for meeting
organization.
Aziende Farmaceutiche/
Diagnostiche
Relazione
Francesca Ceccherini Silberstein
1-Abbott, 2-Bristol Myers Squibb,
3-Gilead Sciences, 4-Janssen Cilag,
5-MSD, 6-ViiV, 7-Roche
Advisory boards: 6
Consulting fees: 3,5,6
Research grants: 5,7
Speakers bureau/lectures: 1,2,3,4,5,6,7
Economical support for meeting
organization: 1,5,6
Alessia Ciancio
1-Roche, 2-MSD,
3-Bristol Myers Squibb,
4-Gilead Sciences, 5-Janssen Cilag,
6-AbbVie
Advisory board: 4, 6
Speakers bureau: 1,2,3,4,5,6
Marco Marzioni
Nessuna
Nessuna
Maria Rendina
1-Roche, 2-MSD,
3-Bristol Myers Squibb,
4-Gilead Sciences, 5-Biotest Italia,
6-Kedrion, 7-Grifols Italia
Advisory board: 1, 2, 6
Speakers bureau: 1,2,3,4,5,6,7
Consulting fees: 6,7
Marco Senzolo
Novartis, Astellas, Biotest, Alexion
Economical support in meeting
organization
Nessuna
Nessuna
AbbVie, GileadSciences, Janssen Cilag
Advisory Board
AbbVie, GileadSciences, MSD,
Janssen Cilag
Speaker Bureau
Davide Bitetto
Nessuna
Nessuna
Raffaele Bruno
AbbVie, Boehringer Ingelheim,
Gilead Sciences, Janssen Cilag,
MSD, Roche
He acted as an advisor and/or lecturer
Salvatore Petta
AbbVie, Janssen Cilag, MSD
Advisory boards, consulting fees
Novartis Farma
Research grant
AbbVie, Gilead Sciences, Janssen Cilag,
MSD, Novartis Farma, Roche
AbbVie, Bristol Myers Squibb,
Gilead Sciences, MSD, Novartis Farma,
Janssen Cilag, Roche
Janssen Cilag
Roche
AbbVie
Gilead Sciences
MSD
Bristol Myers Squibb
Boehringer Ingelheim
Abbott, AbbVie, Bristol Myers Squibb,
Fujirebio, Gilead Sciences,
Janssen Cilag, MSD, Roche
Abbott, Bristol Myers Squibb,
Gilead Sciences, Janssen Cilag, MSD,
Novartis Farma, Roche
Speakers Bureau
Estensore/Revisore
Luca Valenti
Alessio Aghemo
Pierluigi Toniutto
Alfredo Alberti
Pietro Andreone
Ferruccio Bonino
Maurizia Rossana Brunetto
Linee di indirizzo AISF – HCV, Giugno 2014
Advisory board, speakers bureau, research
grants, support for sponsored meetings
Advisory board, speakers bureau
Advisory board, speakers bureau
Advisory board
Advisory board, speakers bureau
Advisory board, speakers bureau
Consulting fee, speakers bureau
Advisory board
Advisory boards, speakers bureau and
economical support for meeting
organization
Speakers' Bureau
27 Estensore/Revisore
Savino Bruno
Nicola Caporaso
Paolo Caraceni
Massimo Colombo
Antonio Craxì
Giovanni Battista Gaeta
Massimo Levrero
Alessandra Mangia
Massimo Puoti
Giovanni Raimondo
Mario Rizzetto
Mariagrazia Rumi
Linee di indirizzo AISF – HCV, Giugno 2014
Aziende Farmaceutiche/
Diagnostiche
AbbVie, Bristol Myers Squibb,
Gilead Sciences, MSD
Relazione
Advisory boards
AbbVie, MSD
Speakers bureau
AbbVie, Bayer, Bristol Myers Squibb,
Gilead Sciences, MSD, Roche
AbbVie, Boehringer Ingelheim,
Gilead Sciences, MSD
Economical support for meeting
organization
Advisory boards
Gilead Sciences, Roche
Research grants
Bristol Myers Squibb, Gilead Sciences,
MSD, Janssen Cilag, Roche
Speaker
Nessuna
Nessuna
MSD, Roche, Bristol Myers Squibb,
Gilead Sciences
Grant and research support
Merck, Roche, Novartis, Bayer, Bristol
Myers Squibb, Gilead Sciences, Tibotec,
Vertex, Janssen Cilag, Achillion,
Lundbeck, Abbott,
Boehringer Ingelheim, GlaxoSmithKline,
GenSpera, AbbVie
Advisory committees
Tibotec, Roche, Novartis Farma, Bayer,
Bristol Myers Squibb, Gilead Sciences,
Vertex
AbbVie,Achillion,
Bayer, Boehringer Ingelheim,
Bristol Myers Squibb, Gilead Sciences,
Inframed, Janssen Cilag, MSD,
Novartis Farma, Roche, Vertex
Janssen Cilag, MSD, AbbVie,
Gilead Sciences, Bristol Myers Squibb
Bristol Myers Squibb
Gilead Sciences
MSD
Janssen Cilag
Roche
AbbVie, Bristol Myers Squibb
Gilead Sciences, Janssen Cilag, MSD,
Roche
AbbVie, Boehringer Ingelheim,
Bristol Myers Squibb, Janssen Cilag,
MSD, Novartis Farma,
Gilead Sciences, Roche
AbbVie, Bristol Myers Squibb,
Gilead Sciences, Janssen Cilag, MSD,
Roche
AbbVie, Bristol Myers Squibb,
Janssen Cilag, MSD
Janssen Cilag, Roche
Speaking and teaching
Advisory boards, consultancy, lecture
fees, clinical trials advisor ship and
participation over the last two years
Speaker and/or Advisor
Speaker, Meeting support
Advisory, Speaker, Meeting support
Speaker, Meeting support
Advisory, Speaker, Meeting support
Speaker, Meeting support
Speaker / Advisory / Research founding
Advisory Boards, Docente in corsi per
personaleInterno, Grant per ricerca,
Speaker in own events
Advisory boards/Speaker bureau
Advisory Board
Advisory Board
Bristol Myers Squibb, Gilead Sciences,
MSD, Roche
Speaker fees
AbbVie, MSD, Roche
Travel grant
28 Estensore/Revisore
Gloria Taliani
Erica Villa
Anna Linda Zignego
Linee di indirizzo AISF – HCV, Giugno 2014
Aziende Farmaceutiche/
Diagnostiche
AbbVie, Boehringer Ingelheim,
Bristol Myers Squibb, Gilead Sciences,
Janssen Cilag, MSD, Novartis Farma,
Roche
1-Roche, 2-MSD,
3-Bristol Myers Squibb,
4-Gilead Sciences,
5-AbbVie, 6-GSK, 7- Novartis Farma
Bristol Myers Squibb, Gilead Sciences,
Janssen-Cilag, MSD, Roche
Relazione
Speaking, Teaching, Advisory Board
Unrestricted research grant: 1, 2
Advisory Board: 2,5,6
Speakers Bureau: 2,3,4,5,6,7
Economical support for meeting
organization, advisory boards, consulting
fees, participation to mono-sponsor
meetings
Author
Document
Category
Uncategorized
Views
0
File Size
135 KB
Tags
1/--pages
Report inappropriate content